Placebo for pirfenidone

DRUG2 trials

Sponsors

Dr. Douglas D. Fraser, Douglas D. Fraser

Conditions

Long COVIDLong Covid

Phase 3

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

RecruitingNCT06928272

Douglas D. FraserLong COVID

Start: 2025-09-10End: 2027-12-01Target: 348Updated: 2026-04-03

Long Covid (LC)-Revitalize - A Long Covid Repurposed Drug Study

WithdrawnCTIS2025-522611-42-00

Dr. Douglas D. FraserLong Covid

Target: 75Updated: 2026-02-25